94 results on '"Jungbauer, Frederic"'
Search Results
2. Laboratory chemical prognostic factors at the start of immunotherapy for head and neck malignancies
3. Risk factors for postoperative complications after reconstruction of head and neck defects with free and pedicled flaps
4. Characterization of the immune microenvironment in a 3D organotypic co-culture model for HNSCC
5. Gene expression profiling as a helpful tool to identify the predictive potential of ex-vivo head and neck cancer models
6. Professionelle Teamarbeit und Kommunikation im Operationssaal – Eine narrative Übersicht
7. Nivolumab as a Promising Treatment Option for Metastatic Salivary Duct Carcinoma.
8. C-Reactive Protein Kinetic as a Potential Predictive and Prognostic Factor during Treatment with Checkpoint Inhibitors in R/M-HNSCC.
9. Risk factors for immune-related adverse effects during CPI therapy in patients with head and neck malignancies – a single center study
10. The effects of COVID-19 on the vestibular system
11. Targeted Treatment of HPV16-positive and -negative SCC Cells With Small Molecule Tyrosine Kinase Inhibitors and Everolimus Affects MMP2 and MMP14 Expression
12. Anosmia Testing as Early Detection of SARS-CoV-2 Positivity; A Prospective Study under Screening Conditions
13. Significance of initial blood parameters on total cumulative dose of cisplatin in HNSCC
14. Was uns interessieren sollte – Dimensionen der Patientenzufriedenheit an einer Universitäts-HNO-Klinik
15. SARS-CoV2 and the vestibular System
16. SARS-CoV2 und die Vestibularorgane
17. What should interest us – dimensions of patient satisfaction at a university ENT clinic
18. Bedeutung der initialen laborchemischen Parameter für die kumulative Gesamtdosis von Cisplatin bei HNSCC
19. Plasma exosomes from Head and Neck Cancer patients: pro- or anti-angiogenic mediators?
20. Prognostic Factors for the Therapeutic Performance of Cisplatin in Head and Neck Malignancies
21. Post-COVID-19 Impairment of the Senses of Smell, Taste, Hearing, and Balance
22. Differentialdiagnostik intraorbitaler Raumforderungen – eine Übersicht
23. Prevalence of subjective impairments of the sense of smell and taste in employees of retirement and nursing homes during SARS‐CoV‐2 pandemic
24. Professionelle Teamarbeit und Kommunikation im Operationssaal – Eine narrative Übersicht
25. Validität präoperativ entnommener SARS-CoV-2-Abstriche bei Kindern
26. Case Report: Bilateral Palsy of the Vocal Cords After COVID-19 Infection
27. Characteristics of hyp- and anosmia in the context of Covid-19 infections
28. Charakteristika von Hyp- und Anosmie im Rahmen von Covid-19 Infektionen
29. Differentialdiagnostik intraorbitaler Raumforderungen – eine Übersicht.
30. Die Tumorstammzellnische im Kopf-Hals-Bereich – Knotenpunkt mit therapeutischem Potenzial?
31. Charakterisierung der immunen Mikroumgebung im 3D-organotypischen Ko-Kulturmodell für Kopf-Hals-Tumoren.
32. Validität präoperativ entnommener SARS-CoV-2-Abstriche bei Kindern.
33. Prevalence of subjective impairments of the sense of smell and taste in employees of retirement and nursing homes during SARS‐CoV‐2 pandemic.
34. FGF Expression in HPV16-positive and -negative SCC After Treatment With Small-molecule Tyrosine Kinase Inhibitors and Everolimus
35. Effect of Small-molecule Tyrosine Kinase Inhibitors on PDGF-AA/BB and PDGFRα/β Expression in SCC According to HPV16 Status
36. HPV-positive und -negative Plattenepithelkarzinome der Kopf-Hals-Region – Interaktionen in der Tumorstammzellnische am Beispiel der SDF-1α/CXCR4-Achse
37. Metastasis of pulmonary adenocarcinoma to the palatine tonsil
38. Plasma exosomes from Head and Neck Cancer Patients modulate Immune Checkpoint Receptors on T cells and attenuate the Efficacy of Immunotherapy in vitro.
39. Metastasis of pulmonary adenocarcinoma to the palatine tonsil.
40. Stage-dependent Effects of Plasma Exosomes from Head and Neck Cancer Patients on Endothelial Cell Function.
41. Patient-specific spheroids from squamous cell carcinoma of the head and neck region (HNSCC) as a tool for personalized therapy.
42. Immune-related adverse events of checkpoint inhibitors as predictive factors in R/M-HNC.
43. Stable disease under checkpoint inhibition in pulmonary metastatic salivary duct carcinoma.
44. Stadienabhängige Effekte der Plasmaexosomen von Patienten mit Kopf-Hals-Tumoren auf die Funktion von Endothelzellen.
45. Plasmaexosomen von Patienten mit Kopf-Hals-Karzinomen modulieren Immun-Checkpoint-Rezeptoren auf T-Zellen und reduzieren die Wirksamkeit der Immuntherapie in vitro.
46. Patientenspezifische Sphäroide aus Plattenepithelkarzinomen der Kopf-Hals-Region (HNSCC) als Instrument zur personalisierten Therapie.
47. Immunbedingte Nebenwirkungen von Checkpointinhibitoren als prädiktive Faktoren bei R/M-HNC.
48. Stable Disease unter Checkpoint-Inhibition bei pulmonal metastasiertem Speichelgangkarzinom.
49. [Differential diagnosis of intraorbital masses - a narrative review].
50. [Validity of SARS-CoV-2 swabs taken preoperatively in children].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.